Unveiling nonischemic cardiomyopathies with cardiac magnetic resonance

References

• Maron BJ, Towbin JA, Thiene G, et al. Contemporary Definitions and Classification of the Cardiomyopathies: An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee. Quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation 2006;113(14):1807-16
   PubMed Web of Science ®Google Scholar
• Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial diseases. Eur Heart J 2008;29(2):270-6
   PubMed Web of Science ®Google Scholar
• Mulvagh SL, DeMaria AN, Feinstein SB, et al. Contrast echocardiography: current and future applications. J Am Soc Echocardiogr 2000;13(4):331-42
   Web of Science ®Google Scholar
• Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 2007;28(24):3076-93
   PubMed Web of Science ®Google Scholar
• Yoshida A, Ishibashi-Ueda H, Yamada N, et al. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure. Eur J Heart Fail 2013;15(2):166-75
   PubMed Web of Science ®Google Scholar
• Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995;92(4):785-9
   PubMed Web of Science ®Google Scholar
• Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet 2013;381(9862):242-55
   PubMed Web of Science ®Google Scholar
• Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005;112(6):855-61
   PubMed Web of Science ®Google Scholar
• Maron MS, Hauser TH, Dubrow E, et al. Right ventricular involvement in hypertrophic cardiomyopathy. Am J Cardiol 2007;100(8):1293-8
   PubMed Web of Science ®Google Scholar
• Schulz-Menger J, Abdel-Aty H, Busjahn A, et al. Left ventricular outflow tract planimetry by cardiovascular magnetic resonance differentiates obstructive from non-obstructive hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2006;8(5):741-6
   PubMed Web of Science ®Google Scholar
• Rubinshtein R, Glockner JF, Feng D, et al. Comparison of magnetic resonance imaging versus Doppler echocardiography for the evaluation of left ventricular diastolic function in patients with cardiac amyloidosis. Am J Cardiol 2009;103(5):718-23
   Google Scholar
• Paelinck BP, de Roos A, Bax JJ, et al. Feasibility of tissue magnetic resonance imaging: a pilot study in comparison with tissue Doppler imaging and invasive measurement. J Am Coll Cardiol 2005;45(7):1109-16
   Google Scholar
• Young AA, Kramer CM, Ferrari VA, et al. Three-dimensional left ventricular deformation in hypertrophic cardiomyopathy. Circulation 1994;90(2):854-67
   PubMed Web of Science ®Google Scholar
• Alter P, Rupp H, Stoll F, et al. Increased end diastolic wall stress precedes left ventricular hypertrophy in dilative heart failure–use of the volume-based wall stress index. Int J Cardiol 2012;157(2):233-8
   PubMed Web of Science ®Google Scholar
• Kim YJ, Choi BW, Hur J, et al. Delayed enhancement in hypertrophic cardiomyopathy: comparison with myocardial tagging MRI. J Magn Reson Imaging 2008;27(5):1054-60
   Google Scholar
• Maron MS. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2101;214:13
   Google Scholar
• Bruder O, Wagner A, Jensen CJ, et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56(11):875-87
   PubMed Web of Science ®Google Scholar
• Maron MS, Appelbaum E, Harrigan CJ, et al. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circulation 2008;1(3):184-91
   Google Scholar
• Adabag AS, Maron BJ, Appelbaum E, et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008;51(14):1369-74
   PubMed Web of Science ®Google Scholar
• Green JJ, Berger JS, Kramer CM, Salerno M. Prognostic Value of Late Gadolinium Enhancement in Clinical Outcomes for Hypertrophic Cardiomyopathy. JACC Cardiovasc Imaging 2012;5(4):370-7
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Voigt T, Chen Z, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 2013;6(4):475-84
   PubMed Web of Science ®Google Scholar
• Dass S, Suttie JJ, Piechnik SK, et al. Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging 2012;5(6):726-33
   PubMed Web of Science ®Google Scholar
• Scharhag J, Schneider G, Urhausen A, et al. Athlete's heart right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J Am Coll Cardiol 2002;40(10):1856-63
   Google Scholar
• Pelliccia A, Maron BJ, Spataro A, et al. The Upper Limit of Physiologic Cardiac Hypertrophy in Highly Trained Elite Athletes. N Engl J Med 1991;324(5):295-301
   PubMed Web of Science ®Google Scholar
• Desnick RJ, Brady R, Barranger J, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003;138(4):338-46
   PubMedGoogle Scholar
• Nakao S, Takenaka T, Maeda M, et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med 1995;333(5):288-93
   PubMed Web of Science ®Google Scholar
• Chimenti C, Pieroni M, Morgante E, et al. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation 2004;110(9):1047-53
   PubMed Web of Science ®Google Scholar
• Pieroni M, Chimenti C, De Cobelli F, et al. Fabry's disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization. J Am Coll Cardiol 2006;47(8):1663-71
   Google Scholar
• De Cobelli F, Esposito A, Belloni E, et al. Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy. AJR Am J Roentgenol 2009;192(3):W97-102
   PubMed Web of Science ®Google Scholar
• Moon JCC, Sachdev B, Elkington AG, et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003;24(23):2151-5
   PubMed Web of Science ®Google Scholar
• Alter P, Rupp H, Adams P, et al. Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy. Eur J Heart Fail 2011;13(9):937-44
   Google Scholar
• Imbriaco M, Spinelli L, Cuocolo A, et al. MRI characterization of myocardial tissue in patients with Fabry's disease. AJR Am J Roentgenol 2007;188(3):850-3
   Google Scholar
• Sado DM, White SK, Piechnik SK, et al. Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging 2013;6(3):392-8
   PubMed Web of Science ®Google Scholar
• Beer M, Weidemann F, Breunig F, et al. Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy. Am J Cardiol 2006;97(10):1515-18
   Google Scholar
• Seward JB, Casaclang-Verzosa G. Infiltrative cardiovascular diseases: cardiomyopathies that look alike. J Am Coll Cardiol 2010;55(17):1769-79
   Google Scholar
• Dara BS, Rusconi PG, Fishman JE. Danon disease: characteristic late gadolinium enhancement pattern on cardiac magnetic resonance imaging. Cardiol Young 2011;21(6):707-9
   Google Scholar
• Basso C, Corrado D, Marcus FI, et al. Arrhythmogenic right ventricular cardiomyopathy. Lancet 2009;373(9671):1289-300
   PubMed Web of Science ®Google Scholar
• Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010;121(13):1533-41
   PubMed Web of Science ®Google Scholar
• Tandri H, Castillo E, Ferrari VA, et al. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol 2006;48(11):2277-84
   Google Scholar
• Tandri H, Saranathan M, Rodriguez ER, et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005;45(1):98-103
   Google Scholar
• Peters F, Khandheria BK. Isolated left ventricular noncompaction: what do we really know? Curr Cardiol Rep 2012;14(3):381-8
   Google Scholar
• Oechslin EN, Attenhofer Jost CH, Rojas JR, et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 2000;36(2):493-500
   PubMed Web of Science ®Google Scholar
• Dursun M, Agayev A, Nisli K, et al. MR imaging features of ventricular noncompaction: emphasis on distribution and pattern of fibrosis. Eur J Radiol 2010;74(1):147-51
   Google Scholar
• Saleeb SF, Margossian R, Spencer CT, et al. Reproducibility of echocardiographic diagnosis of left ventricular noncompaction. J Am Soc Echocardiogr 2012;25(2):194-202
   PubMed Web of Science ®Google Scholar
• Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005;46(1):101-5
   PubMed Web of Science ®Google Scholar
• Dodd JD, Holmvang G, Hoffmann U, et al. Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI: correlation with clinical severity. AJR Am J Roentgenol 2007;189(4):974-80
   Google Scholar
• Thuny F, Jacquier A, Jop B, et al. Assessment of left ventricular non-compaction in adults: side-by-side comparison of cardiac magnetic resonance imaging with echocardiography. Arch Cardiovasc Dis 2010;103(3):150-9
   Web of Science ®Google Scholar
• Gulati A, Jabbour A, Ismail TF, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 2013;309(9):896-908
   PubMed Web of Science ®Google Scholar
• Wu KC, Weiss RG, Thiemann DR, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008;51(25):2414-21
   PubMed Web of Science ®Google Scholar
• Sarda L, Colin P, Boccara F, et al. Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J Am Coll Cardiol 2001;37(3):786-92
   Google Scholar
• Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 2009;53(17):1475-87
   PubMed Web of Science ®Google Scholar
• Sechtem U, Mahrholdt H, Vogelsberg H. Cardiac magnetic resonance in myocardial disease. Heart 2007;93(12):1520-7
   PubMed Web of Science ®Google Scholar
• Laissy J-P, Messin B, Varenne O, et al. MRI of acute myocarditis: a comprehensive approach based on various imaging sequences. Chest 2002;122(5):1638-48
   Google Scholar
• Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109(10):1250-8
   PubMed Web of Science ®Google Scholar
• Lurz P, Eitel I, Adam J, et al. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC Cardiovasc Imaging 2012;5(5):513-24
   PubMed Web of Science ®Google Scholar
• Zagrosek A, Abdel-Aty H, Boyé P, et al. Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging 2009;2(2):131-8
   PubMedGoogle Scholar
• Mahrholdt H, Sechtem U. Noninvasive differentiation between active and healed myocarditis by cardiac magnetic resonance: are we there yet? JACC Cardiovasc Imaging 2009;2(2):139-42
   Google Scholar
• Ferreira VM, Piechnik SK, Dall'Armellina E, et al. T1 Mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging 2013;6(10):1048-58
   PubMed Web of Science ®Google Scholar
• Thavendiranathan P, Walls M, Giri S, et al. Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping. Circulation 2012;5(1):102-10
   Google Scholar
• Maisch B, Pankuweit S. Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy. Herz 2012;37(6):644-56
   PubMed Web of Science ®Google Scholar
• Maisch B, Seferović PM, Ristić AD, et al. Guidelines on the diagnosis and management of pericardial diseases executive summary: the task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology. Eur Heart J 2004;25(7):587-610
   PubMed Web of Science ®Google Scholar
• Alter P, Figiel JH, Rupp TP, et al. MR, CT, and PET imaging in pericardial disease. Heart Fail Rev 2013;18(3):289-306
   PubMedGoogle Scholar
• Ribeiro AL, Nunes MP, Teixeira MM, Rocha MOC. Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol 2012;9(10):576-89
   PubMed Web of Science ®Google Scholar
• Rochitte CE, Oliveira PF, Andrade JM, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol 2005;46(8):1553-8
   Google Scholar
• Regueiro A, García-Álvarez A, Sitges M, et al. Myocardial involvement in Chagas disease: insights from cardiac magnetic resonance. Int J Cardiol 2013;165(1):107-12
   PubMed Web of Science ®Google Scholar
• Abe Y, Kondo M, Matsuoka R, et al. Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol 2003;41(5):737-42
   PubMed Web of Science ®Google Scholar
• Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P, et al. CLinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA 2011;306(3):277-86
   PubMed Web of Science ®Google Scholar
• Akashi YJ, Goldstein DS, Barbaro G, Ueyama T. Takotsubo Cardiomyopathy: a New Form of Acute, Reversible Heart Failure. Circulation 2008;118(25):2754-62
   PubMed Web of Science ®Google Scholar
• Elesber AA, Prasad A, Lennon RJ, et al. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol 2007;50(5):448-52
   PubMed Web of Science ®Google Scholar
• Karamitsos TD, Bull S, Ferreira V, et al. Acute myocarditis mimicking reverse Takotsubo cardiomyopathy. [Erratum appears in]. Circulation 2011;124(12):e335-Circulation 2011;123(2):226-7
   Google Scholar
• Ferreira VM, Piechnik SK, Dall'Armellina E, et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012;14:42
   Google Scholar
• Karaye KM, Henein MY. Peripartum cardiomyopathy: a review article. Int J Cardiol 2013;164(1):33-8
   Google Scholar
• Sliwa K, Fett J, Elkayam U, et al. Peripartum cardiomyopathy. Lancet 2006;368:9536-687
   Google Scholar
• Barone-Rochette G, Rodiere M, Lantuejoul S. Value of cardiac MRI in peripartum cardiomyopathy. Arch Cardiovasc Dis 2011;104(4):263-4
   Google Scholar
• Arora NPMD, Mohamad TMD, Mahajan NMD et al. Cardiac magnetic resonance imaging in peripartum cardiomyopathy: a new tool to evaluate an old enigma. Am J Med Sci 2013. [ Epub ahead of print]
   Google Scholar
• Mouquet F, Lions C, de Groote P, et al. Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. Eur Radiol 2008;18(12):2765-9
   PubMed Web of Science ®Google Scholar
• Hertz MI, Aurora P, Christie JD, et al. Scientific Registry of the International Society for Heart and Lung Transplantation: introduction to the 2009 Annual Reports. J Heart Lung Transplant 2009;28(10):989-92
   Google Scholar
• Muehling OM, Wilke NM, Panse P, et al. Reduced myocardial perfusion reserve and transmural perfusion gradient in heart transplant arteriopathy assessed by magnetic resonance imaging. J Am Coll Cardiol 2003;42(6):1054-60
   Google Scholar
• Kyle RA. Amyloidosis. Circulation 1995;91(4):1269-71
   Google Scholar
• Krombach GA, Hahn C, Tomars M, et al. Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects. J Magn Reson Imaging 2007;25(6):1283-7
   Google Scholar
• Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111(2):186-93
   PubMed Web of Science ®Google Scholar
• Austin BA, Tang WHW, Rodriguez ER, et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging 2009;2(12):1369-77
   PubMed Web of Science ®Google Scholar
• Maceira AM, Prasad SK, Hawkins PN, et al. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 2008;10:54
   PubMed Web of Science ®Google Scholar
• Bonnichsen CR, Glockner JF, Grogan M. Improvement in myocardial delayed enhancement after autologous stem cell transplant in a patient with light chain amyloidosis. Circulation 2012;5(3):e55
   Google Scholar
• Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 2013; 6(4): 9
   Google Scholar
• Aessopos A, Berdoukas V, Tsironi M. The heart in transfusion dependent homozygous thalassaemia today–prediction, prevention and management. Eur J Haematol 2008;80(2):93-106
   PubMedGoogle Scholar
• Kremastinos DT, Tsiapras DP, Tsetsos GA, et al. Left ventricular diastolic Doppler characteristics in β-thalassemia major. Circulation 1993;88(3):1127-35
   PubMed Web of Science ®Google Scholar
• Anderson LJ, Westwood MA, Prescott E, et al. Development of thalassaemic iron overload cardiomyopathy despite low liver iron levels and meticulous compliance to desferrioxamine. Acta Haematol 2006; 115(1-2): 106-8
   Google Scholar
• Chouliaras G, Berdoukas V, Ladis V, et al. Impact of magnetic resonance imaging on cardiac mortality in thalassemia major. J Magn Reson Imaging 2011;34(1):56-9
   PubMed Web of Science ®Google Scholar
• Mavrogeni SI, Markussis V, Kaklamanis L, et al. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with β-thalassemia major. Eur J Haematol 2005;75(3):241-7
   Google Scholar
• Carpenter J-P, He T, Kirk P, et al. On T2* magnetic resonance and cardiac iron. Circulation 2011;123(14):1519-28
   PubMed Web of Science ®Google Scholar
• Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22(23):2171-9
   PubMed Web of Science ®Google Scholar
• Patton N, Brown G, Leung M, et al. Observational study of iron overload as assessed by magnetic resonance imaging in an adult population of transfusion-dependent patients with beta thalassaemia: significant association between low cardiac T2* <10 ms and cardiac events. Intern Med J 2010;40(6):419-26
   PubMed Web of Science ®Google Scholar
• Kirk P, Roughton M, Porter JB, et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 2009;120(20):1961-8
   PubMed Web of Science ®Google Scholar
• Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995;119(2):167-72
   PubMed Web of Science ®Google Scholar
• Schaedel H, Kirsten D, Schmidt A, et al. Sarcoid heart disease–results of follow-up investigations. Eur Heart J 1991;12(Suppl D):26-7
   Google Scholar
• Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999;138(2 Pt 1):299-302
   PubMed Web of Science ®Google Scholar
• Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 2005;184(1):249-54
   Google Scholar
• Smedema J-P, Snoep G, van Kroonenburgh MPG, et al. The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 2005;128(3):1629-37
   Google Scholar
• Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009;120(20):1969-77
   PubMed Web of Science ®Google Scholar
• Greulich S, Deluigi CC, Gloekler S, et al. CMR Imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging 2013;6(4):501-11
   PubMed Web of Science ®Google Scholar
• Vignaux O, Dhote R, Duboc D, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 2002;122(6):1895-901
   PubMed Web of Science ®Google Scholar
• Valent P, Klion AD, Horny H-P, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 2012;130(3):607-12; e609
   PubMed Web of Science ®Google Scholar
• Syed IS, Martinez MW, Feng D-L, Glockner JF. Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease. Int J Cardiol 2007;126(3):e50-2
   Google Scholar
• Finsterer J, Stollberger C. Cardiac involvement in primary myopathies. Cardiology 2000;94(1):1-11
   PubMed Web of Science ®Google Scholar
• Silva MC, Meira ZMA, Gurgel Giannetti J, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 2007;49(18):1874-9
   PubMed Web of Science ®Google Scholar
• Fallah-Rad N, Walker JR, Wassef A, et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol 2011;57(22):2263-70
   PubMed Web of Science ®Google Scholar
• Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 2013;6(4):488-97
   PubMed Web of Science ®Google Scholar